MedTrace Logo

Feasibility and Impact of Malaria Rapid Diagnostic Tests in the African Retail Sector

NCT01652365 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2800

Last updated 2012-07-30

No results posted yet for this study

Summary

The purpose of this study is to assess the feasibility and impact of introducing subsidized malaria rapid diagnostic tests (RDTs) into retail sector drug shops in Uganda. This is a randomized controlled trial at the village level, taking place in 6 districts in Eastern Uganda. Licensed drug shops in selected villages were trained in proper RDT storage, administration, interpretation and disposal and were given access to subsidized RDTs for sale. This study explores whether drug shop owners--when given access to training and subsidized RDTs--will choose to promote and sell RDTs to customers and, if so, at what volume and what price. The investigators also explore whether shops will safely store, administer, interpret and dispose of RDTs and to what extent they will use RDT results to guide treatment recommendations. Finally, the study explores whether making RDTs available for sale in local drug shops has a community level impact on diagnostic testing and appropriate treatment for malaria.

Conditions

Interventions

BEHAVIORAL

RDT Training and Subsidy Offered

BEHAVIORAL

Information/Education Campaign

Sponsors & Collaborators

  • Clinton Health Access Initiative, Nigeria

    collaborator OTHER

  • Innovations for Poverty Action-Uganda

    collaborator UNKNOWN

  • Uganda Health Marketing Group

    collaborator UNKNOWN

  • Harvard School of Public Health (HSPH)

    lead OTHER

Principal Investigators

  • Jessica Cohen, PhD · Harvard School of Public Health (HSPH)

  • Gunther Fink, PhD · Harvard School of Public Health (HSPH)

  • William Dickens, PhD · Northeastern University

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2012-06-30
Completion
2012-06-30

Countries

  • Uganda

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01652365 on ClinicalTrials.gov